La Jolla Pharmaceutical Company

Start Date End Date Funded Value Relevance

CSV

25 50 100

£2,060,000

Apr 17 - Mar 23

Hepcidin and its Regulatory Pathways in Malaria and in Adaptive Immunity

MRC award to University of Oxford and Hal Drakesmith

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}